Dror Berman

Some VC investors believe that brick and mortar - referring to a physical presence of some kind - should be avoided at all costs. Yet, the track record of clinic and hybrid care businesses in health care indicates otherwise. ==> One Medical (sold for $3.9 billion to Amazon), Oak Street (bought by CVS for $10.6 billion), Lifestance (IPO at $7.5 billion market cap), and PE-backed Premise Health (acquired by OMERS Private Equity for $1.1 billion) If a clinic is indicated as the optimal way to deliver care for that patient population, there are creative ways to build and operate them. Full article below with advice and strategies on how to build and operate hybrid clinics from my teammate Anarghya Vardhana from Maveron, Amir Dan Rubin from OneMedical Group, Steven Eidelman from Modern Animal and more!

13

1 Comment

No founder wants to pitch a VC with no cash.  That’s why we’re sharing the list of firms below that have fresh capital to deploy. 🔴 Barcelona based Asabys Partners closed its second $201.3M fund to invest in biotech, med-tech, and digital health companies. 🔴 Chicago based ARCH Venture Partners closed its thirteenth $3B fund to focus on biotechnology companies. 🔴 Palo Alto based DCVC closed its third $400M biotech fund to back data-driven life science businesses. 🔴 Miami based Boldstart Ventures raised its seventh $250M fund to invest in enterprise infra and SaaS startups. 🔴 New York based The Fintech Fund raised its second $10M fund to focus on founders with strong backgrounds in building financial products.

50

6 Comments

M13 is thrilled to lead the Series A in RadiantGraph which is focused on personalization in healthcare. As we continue to invest in early stage companies it is abundantly clear that the biggest indicator of success is the founder and his or her ability to execute on their vision of the future. In this case, I don't think I have seen much better founder-market fit than we have with founder and CEO Anmol Madan. We believe in his vision: in order to have the best patient outcomes in healthcare we need increased personalization and AI is the breakthrough to get us there. Anmol started one of the pioneering digital health companies Ginger and then was Chief Data Scientist at Livongo and Teledoc. He has done it all: early stage, late stage, public company. And he deeply understands the nuances of the healthcare market from all angles which is critical for success. While there are many players building healthcare-specific AI capabilities, RadiantGraph is focused on outcomes: The platform is already processing personalization models for more than 3.5 million people, despite launching just last year. Excited to partner with my friend Adam D'Augelli and the great True Ventures again and Morgan Blumberg who has been deep in the healthcare market with me for many years. More on our thesis in the blog below. https://lnkd.in/evDDmC3W

72

4 Comments

San Diego investor event: Aquillius Medical Devices & Diagnostics Symposium, taking place on Wednesday, May 15th, from 12:30 PM to 7:00 PM. This exclusive event brings together leading industry experts, groundbreaking startups, and prominent investors like yourself. Here's what you can expect: Expert Insights: Gain valuable knowledge from renowned speakers on topics critical to medtech success, including design for manufacturing, intellectual property protection, regulatory navigation, and fostering successful startups. Early Access to Innovation: Witness the future of healthcare firsthand as promising Aquillius incubees showcase their innovative medical device and diagnostic solutions during a dedicated startup showcase. Networking Opportunities: Connect and build relationships with other investors, entrepreneurs, and industry leaders shaping the medical technology landscape. This is a unique opportunity to: Identify promising investment opportunities in the medtech sector. Gain valuable insights from leading experts. Network with a community of like-minded investors and industry professionals. Space is limited, so RSVP today! Medical Devices Symposium (Investor Registration) Tickets, Wed, May 15, 2024 at 12:30 PM | https://lnkd.in/gjWDU9pz

4

One of my proudest moments as an investor occurred today as Alaffia Health announced its series A because it shows how the Aperture® Venture Capital vision of multi-level, multi-generational #impactinvesting is succeeding in the marketplace. Here’s the model in its most basic form : ✅As diverse fund managers with meaningful capital to allocate, we are changing the VC landscape every day just by doing our day jobs. ✅As Black/Brown investors with ~40 years experience collectively, Aperture GPs have access to talent /excellence that others do not, so our portfolio *organically* is more inclusive by race, gender and geography even while optimizing for financial outcomes (all about the alpha). ✅Our most successful portco’s are using financial #innovation to solve market problems that impact underrepresented demographics and underserved communities. Alaffia Health is a shining example of the impact portion of our overall fund thesis, and we couldn’t be prouder of TJ Ademiluyi and Adun Akanni, MPH, PMP - the dynamic brother-sister founder duo whose vision we have steadfastly supported on their journey. Congratulations to TJ and Adun from William Crowder and myself, as well as the whole Aperture team- Marjorie King Philip McKenzie Yves Louis-Jacques Tanvi Lal Michelle Dhansinghani Lisha Bell Katie Kelly Amy Chung Cindy Chong, CFA Brian Fernandes-Halloran Monroe France Jayden Pantel Darren Herman Evan Wladis Neal Triplett Thomas Scriven Peter Ammon Irina Bit-Babik Tim Milanich Rob Rahbari

38

18 Comments

👀 Looking at our recent investments at Draper Associates, here’s what standout founders nailed, making our decision to invest much easier (and faster): 💥 Visionary Tech with a Bold Vision – These founders are not here for incremental wins; they’re reimagining what’s possible in across tech - biotech, robotics, aerospace, and beyond. Their vision is big and audacious, tackling complex problems that demand breakthrough solutions, others have not been willing to try. 👊 Clear Passion & Purpose – The drive in these founders is undeniable. They’re committed to their mission with a depth of purpose that shapes every choice. One founder, for example, took two years completely off to learn and meet everyone in longevity biotech. This level of grit and dedication is rare but essential for the most impactful founders. 🌟 Assembling All-Star Teams – They bring together top-tier talent from diverse disciplines: experienced business leaders with successful exits or industry experience at top companies, technical co-founders with deep expertise, often PhDs or industry pioneers, and even published authors. It’s a complementary team, unified by a shared vision. They make the: "Why this team?" obvious - at a glance. 💻 Data-Driven to the Core – These founders present data insights that show why their approach is unique, especially against a competitive field of companies. This data is delivered with clarity and they make the complex simple. Many are published in top journals, adding depth and credibility to their approach, and reinforcing that they know their tech inside out. ⚡️ Memorable, Clear Vision – They don’t just pitch; they make the future feel tangible, with a vision that’s both compelling and concise. If I can relay their pitch in under 30 seconds to my team, they’ve killed it. 📣 Transparent & Proactive Communication – The best founders don’t wait for questions. They come prepared, often with a comprehensive FAQ doc, give timely updates to our questions, and are candid about challenges. This level of openness builds trust and strengthens our partnership. 💸 Milestone-Driven Funding Strategy – Each funding stage aligns clearly with already achieved or upcoming achievable milestones. They’ve mapped out a roadmap that minimizes risk at every step, giving us confidence in their journey. 💰 Revenue Milestones Along the Way – Even if it'll take a decade to hit revenue on their big vision, these founders find revenue generation stops along the way to profitability. They share a trajectory that connects early wins to revenue, showing how every step is a building block toward their bigger vision. Overall, the best founders are incredibly thoughtful, prepared, and fantastic verbal / written communicators. #founders #startups #fundraising #VC

34

2 Comments

Excited for this one. Congrats to Alex Cohen and Hello Patient on their seed round announcement. Hello Patient stands to change the communication paradigm between patients and providers forever. Their generative AI call agent technology is tackling the tremendous admin burden of patient facing comms (scheduling, follow ups, referrals, prescription refills, etc). Massive opportunity and we think Alex and his team are expertly positioned to become market leaders. Max Ventures is thrilled to co-lead the seed round with 8VC and Bling Capital A great quote below from Alex highlighting the concept of "service as a software". Healthcare is a heavily service oriented industry - so the opportunity for step change is even more profound. The startup's approach is part of a paradigm shift where AI companies are offering service as software. "I'm a big believer that the right way to do this is through a managed services business. We're not building SaaS. I believe we can do this services as software where what was traditionally a services business now has software margins because I don't have to go employ a whole bunch of people to do the services under the hood," Cohen noted. https://lnkd.in/ehNN2AmW

24

2 Comments

🎬 Matt Damon and 🏈 Colin Kaepernick have invested in it, and so has 💰Andreessen Horowitz... Function Health's executive team has "engineered a first-of-its-kind approach that focuses on prevention and empowerment"—very much in line with what we aimed to achieve with Carebook when we started it over six years ago. Could they be the ones to fulfill their lead investors' prophecy (link at the bottom) and Dr. Eric Topol, MD's premonitions in his books "The Patient Will See You Now" and "Deep Medicine"? They have just secured a $50 million grant. Let's hope this is not another Theranos and that we are truly witnessing the rise of the next generation of direct-to-consumer health companies. These companies will be key players in the "transition from reactive to proactive" health care that the system—and we—desperately need. What do you think? Links: 📝 Investment round press release: https://lnkd.in/eUG87qkf 🔗 Andreessen Horowitz's prophecy: https://lnkd.in/eZATCf4f

4

Good Q&A with Dash Bio co-founders on their story going from Moderna to a startup and how they intend to use AI and robotics to transform clinical bioanalysis https://lnkd.in/gmmiq4dQ

30

Autonomous Vehicle (AV) funding is surging, according to PitchBook with Q2 2024 seeing $2.9 billion invested in AV startups - the highest since Q3 2021. While self-driving cars grab headlines, innovative startups are finding unique applications beyond passenger vehicles. Key developments: - Supply chain optimization: Outrider is revolutionizing yard operations with autonomous electric vehicles, addressing a $60 billion market. - Specialized transport: Pyka's autonomous planes for cargo and Gatik's local distribution trucks are gaining traction. - Safety & efficiency: Evitado Technologies automates airside operations, mitigating airport collision risks. Of course, more established companies such as Lyft & Uber are working on AV rideshare integration via partnerships with Waymo, BYD, Zoox, and others. The AV sector is focusing on gradual integration and specific use cases. While concerns about job displacement exist, proponents argue that automation could shift human capital to higher-value roles. What those roles are remains to be seen. As the AV landscape evolves, it's clear that the future of transportation extends far beyond just self-driving cars on city streets. Check out the full article by Nadine Manske here: https://lnkd.in/g3HJXZHc? And access the PitchBook Mobility Tech Report here: https://lnkd.in/g4_xP5pr #VentureCapital #AutonomousDriving #FrontierTech #FutureMobility

13

2 Comments

The (Healthcare) Ground Beneath Our Feet… This year it is likely that over $10 billion will be invested in the digital health sector – a robust amount, no doubt, but inconsequential when compared to the amount of capital tied up in healthcare real estate assets, which is estimated to be $1.2 trillion by Jones Lang Lasalle. Of that amount, approximately $790 billion is in the hospital sector while the remaining $490 billion is in medical office assets. It is estimated that there are 48.6k facilities with 3.4 billion square feet of healthcare real estate, 42% of which are owned by REITs and another 33% held by other private investment vehicles. Much of the digital health investment is meant to make the physical healthcare infrastructure more productive: greater operating efficiencies, greater patient throughput, more relevant personalized care models with better outcomes. As the healthcare system is being pushed to be more distributed to lower cost sites of care, accelerated now by the rapid proliferation of automation and AI capabilities, the potential impact on healthcare infrastructure assets will be profound. Thoughts on what that might look like... https://lnkd.in/eTfAdUbS #digitalhealth Flare Capital Partners

97

5 Comments

The most talked about AI x Medical startup Abridge is working to rescue doctors from the never-ending admin grind (which causes burnout and less patient face-time). Abridge's AI listens to patient visits and generates precise medical notes, slashing the clerical workload. Now, doctors can focus on what truly matters: patient care. Major health systems like Yale and Emory are already on board and raving, calling it "life-changing" and "magical." 🔷 A big reason --> Payback of the scribe tool is easy to measure. It supports 14 languages including Haitian Creole, Brazilian Portuguese, and Punjabi. An ongoing criticism of generative AI is that it still has few substantive business applications. This seems to quash that. Question: is a dedicated medical LLM needed to be successful in the space? Or will the huge foundational models (GPT-4o, Google, and Meta) ingest a plethora of medical notes and kill the competition with performance? We're dealing with a fast and furious pace, and today's edge may not be relevant tomorrow. Competitors include Microsoft-owned Nuance Healthcare , Ambience Healthcare, Nabla and Suki. I'm excited to continue to see this field revolutionized. 🌟 #AI #MedTech #Abridge #HealthTech

12

5 Comments

At Two Bear Capital our definition of value-add, lead, early-stage investing is to form a true partnership with the founders we back. We believe that only a small fraction of our return potential comes from us “picking right” when we make our first investment into a company – the vast majority comes from how effectively we can actively help our brilliant founders over the ensuing 3-7 years in achieving the passionate, ambitious, and positive-impact goals that drive them.

22

1 Comment

Open-source models can be a strong lever for increasing gross margins at AI companies, especially those that have hefty cost structures (e.g., enterprise sales orgs that require significant customer success or implementation resources, as well forward-deployed AI services models common in healthcare and life sciences). One of many reasons to maintain a modular and flexible stack with minimal dependencies when building an AI company. More on the importance of flexibility in the AI stack: https://lnkd.in/eA2XATRk h/t Delip Rao #ai #artificialintelligence #generativeai #healthcare

50

6 Comments

14 SiliconXL / DevAccelerator Powered Startups Launch in Stealth Providence, RI - Tuesday, September 24th The SiliconXL Startup Demo Day brought together a remarkable collection of AI-powered tech startups, demonstrating that the event was about far more than just polished pitch decks—it was a showcase of full-stack software engineering, AI, true innovation and customer-validated market demand. DemoDay Startups - Providence took place during RI Startup Week, with tremendous support from RIHub. Each startup, built from the ground up by technical founders, presented AI-driven solutions designed to solve real-world problems. This event emphasized the importance of market fit, with every startup validating their concept through direct interaction with potential users, showcasing not only their technical prowess but their ability to engage with and fulfill market needs. For many of the entrepreneurs showcased at the SiliconXL Startup Demo Day, this was their first experience building a full-stack application. In fact, virtually none of them had ever launched or scaled a tech startup before. Their journey from novice to technical founder was nothing short of transformative, a direct result of their time learning software engineering and AI under the mentorship of Claude Arnell Milhouse and Clifton Choiniere at DevAccelerator. Through DevAccelerator's intensive training and guidance, these founders have not only acquired the technical skills to develop cutting-edge AI solutions but have also gained the entrepreneurial mindset to launch and grow successful startups. This Demo Day is a testament to the profound impact that mentorship, education, and determination can have on an individual's ability to create something that will disrupt industries and transform their own lives in the process. What set this Demo Day apart was the potential for explosive growth, as SiliconXL is laser-focused on launching a tidal wave of startups across multiple markets in the upcoming months and years. From the buzzing streets of Boston and New York to the previously unknown startup market of Providence, the goal is clear: to create a tsunami of high-growth startup activity.  SiliconXL is also dedicated to ensuring that diverse communities not only have a seat at the table but are also leading the charge, amplifying voices that have been historically marginalized. With this Demo Day, it’s evident that SiliconXL is igniting a movement that will leave a lasting mark on the future of AI-powered innovation. Look for more events powered by DemoDay Startups in the months to come in a city near you (Hint: Boston, NYC and up to 16 more startups out of Providence this year). Let's GEEEEEKING Goooooo!!!! #Startups #TechnicalFounders #SoftwareEngineers #Providence #Boston #NewYork #Roxbury #Dorchester #Brooklyn #Queens #TheBronx #Harlem

49

2 Comments

While the best startups are doing well, even in this tough venture capital market, others are struggling to raise new funding. If they can’t raise and haven’t become self-sustaining businesses, their best bet is to get acquired, even if it’s for a fraction of their last valuation. The alternative would be to run out of money and shut down.  https://lnkd.in/eGH64we5 Stay curious, stay informed, and stay tuned to OniX OnPoint! Subscribe to the OniX OnPoint Newsletter to stay updated on the latest biomedical innovations. https://lnkd.in/edUVWht9

2

For those of you still doubting Artificial Intelligence....wake the f$%& up!!! Go walk around downtown San Francisco and maybe all of Google's Waymo driverless cars on the streets may be a wake up call for you. If you need more proof take a look at Y Combinator's current cohort of companies as well as all the AI and AI-Enabled companies in the MedTech Innovator current cohort of companies or the ones pitching at LSI and LSI Europe!

14

PTN raw deal data 24/09/2024: Scribenote / $8.2M / Canada / AI-powered medical scribe for veterinarians / Andreessen Horowitz, Inovia Capital, Velocity Fund Pyka / $40M / USA (Alameda, CA) / Autonomous electric aircraft / Obvious Ventures, Piva Capital, Prelude Ventures, Metaplanet Holdings, Y Combinator Invizius / £950k / UK (Edinburgh, Scotland) / Biotech treatments for dialysis patients / Mercia Ventures, Calculus Capital, Syensqo, University of Edinburgh’s Old College Capital, Scottish Enterprise Letta / $10M / USA (San Francisco, CA) / Generative AI / Felicis, Sunflower Capital, Essence VC, Various Angels MetOx International / $25M / USA (Houston, TX) / High-temperature superconducting wire / Centaurus, New System Ventures Jump / €11M ($12M) / France (Paris) / Freelancer benefits / Breega, Index Ventures, Raise Ventures Fal.ai / $23M / USA / AI-generated audio, video, images platform / Andreessen Horowitz, Kindred Ventures, Robin Rombach, Aravind Srinivas mbue / $1.8M / USA (Austin, TX) / AI-first construction tech / Techstars, Geek Ventures, 2045 Ventures, Spatial Capital, Factorial Capital David Energy / $23M / USA (NYC) / Grid technology / Cathay Innovation, Union Square Ventures, Keyframe Capital, Equal Ventures, BoxGroup HavocAI / $11M / USA (Providence, RI) / Autonomous uncrewed surface vessel technology / Scout Ventures, Trousdale Ventures, Outlander VC Kestra Technologies / $8M / France (Paris) / Event-driven orchestration platform / Alven, ISAI, Axeleo Capital, Various Angels Integrum ESG / £3.4M / UK (London) / ESG data insights platform / YFM Equity Partners Sparrow BioAcoustics / $13M / Canada (St. John’s) / Bioacoustic AI technology / Killick Capital, Klister Credit, Pelorus Ventures Vicebio / $100M / UK (London) / Novel vaccines for respiratory infections / TCGX, Goldman Sachs Alternatives, Avoro Ventures, venBio GPDQ / £1.2M / UK (London) / Primary healthcare provider / IW Capital FluoRok / £7.7M / UK (Oxford) / Fluorochemical reagents and battery electrolyte salts / BGF, Green Generation Fund arqu / $10M / USA (San Francisco, CA) / Wholesale insurance brokerage / Crosslink Capital, Intact Ventures, Lightspeed Venture Partners, Foxe Capital, Nationwide Ventures GC Therapeutics / $65M / USA (Cambridge, MA) / Cell therapy-based medicines / Cormorant Asset Management, Mubadala Capital, Andreessen Horowitz Bio + Health Alan / €173M / France (Paris) / Health insurer / Belfius Bank, Teachers’ Venture Growth, Temasek, Coatue, Lakestar Amnis Finance / $2M / USA / Liquid staking protocol on Aptos blockchain / OKX Ventures, Aptos Labs, Arkgrow Pte Ltd, Ambush Capital, Gate Ventures, Turneo / €2M / UK (London) / Travel tech startup / Bessemer Venture Partners, Underline Ventures Permissionless Labs / $10M / USA (San Francisco Bay Area) / Content delivery network (CDN) on Solana / Multicoin Capital, Robot Ventures, Sorted Wallet / $1.5M / Hong Kong / Cryptocurrency access platform / Tether Operations Limited

8

Insightful look into bioplatform strategy, and what it takes to raise a Series A from my partner, Omri Amirav-Drory: https://lnkd.in/dFv7GbF6

17